Intuitive Surgical beats quarterly estimates on demand for surgical robots

Intuitive Surgical on Thursday beat Wall Street ‍estimates for fourth-quarter profit and revenue on growing demand for its ⁠surgical robots used in minimally invasive procedures.

Shares of the Sunnyvale, California-based company rose 3.3% in after-hours trading.

The medical device maker has ‌seen consistent ‌growth as hospitals work through a backlog of deferred procedures and ‌expand access to minimally invasive care.


Intuitive's da Vinci surgical robots are widely used for a range of procedures including weight-loss surgeries and treatments for digestive, bladder and heart conditions.

The volume of da Vinci procedures ​globally rose about 18% from a year ago ‌in the ‍reported quarter, the company said.

More than 80% ‍of the instruments and accessories for the system ‌are produced at Intuitive's facility in Mexico. The company also operates in China and other international markets.

Intuitive expects da Vinci-assisted procedures to increase about 13% to 15% worldwide this year, compared with 18% growth in 2025.

It also expects 2026 gross profit ‍margin between 67% and 68% of revenue, compared with 67.6% in 2025. This range ‍includes an ⁠estimated impact from ⁠tariffs of 1.2% of revenue, plus or minus 10 basis points, the company said.

On an adjusted basis, Intuitive earned $2.53 per share for the quarter ended December 31, beating analysts' estimates of $2.26 per share, according to data compiled by LSEG.

It reported quarterly revenue of $2.87 billion, compared with analysts' estimates of $2.75 billion.